Two HPLC methods such as cefadroxil and cefalexin methods were compared in their performance for the quantitative analysis of the content and purity of β-lactamic antibiotic, cefradine, for six bulk drug samples.
Introduction
Cefradine is an important cephalosporin antibiotic drug. Cefalexin is a major impurity in cefradine. For the analysis of cefradine and cefalexin, micellar electrokinetic chromatography by the capillary electrophoresis method, 1 liquid chromatography (LC) on poly(styrene-divinylbenzene), 2 a comparative study of two isocratic liquid chromatography methods using a classical column (C 18 ) and poly(styrenedivinylbenzene) as the stationary phase 3 and thin-layer chromatography (TLC) 4 method have been reported. Cephalosporins are commonly analyzed using LC methods with absorbance detection. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Official methods to assess antibiotic identity, strength, quality, and purity of cephalosporins are described in the Code of Federal Regulations (CFR Title 21), the United States Pharmacopoeia (USP) and the European Pharmacopoeia (EP).
In the EP 18 and USP, 19 an isocratic HPLC method was developed and validated for determination of cefalexin, the major impurity in cefradine. However, this method does not allow for characterization of any extraneous impurities. The analytical methods prescribed by the EP and USP for analysis of impurities in cefradine and cefadroxil are summarized in Table 1 . As shown in Table 1 , a TLC method is prescribed by the EP for determination of extraneous impurity levels in cefradine. The TLC method is simple and does not require special equipment. However, it is rarely used to analyze impurities due to its low sensitivity and low reproducibility compared with HPLC method. 20 HPLC method is the most widely used technique for analysis of bulk drugs and their formulations. 21, 22 As shown in Table 2 , limitations on the allowable impurity content in cefradine are clearly described by the EP and USP. Even though a rapid and simple HPLC method has been developed to assay antibiotic and impurity levels in bulk drugs, 21 the official method for determination of extraneous impurities in cefradine is TLC method according to the EP and USP as shown in Table 1 .
In this study, as an effort to propose more reliable method than TLC method, the content of cefradine and all impurities will be assayed for six cefradine bulk drugs by using the cefalexin method, the official HPLC method prescribed by the EP for analyzing cefalexin, the major impurity in cefradine. In addition, the content of cefradine and all impurities will be assayed by using the cefadroxil method, the official HPLC method prescribed by the EP for all 23 Comparison of the two HPLC methods is expected to provide more reliable method than TLC method for determination of the content of cefradine and its all impurities.
Experimental
Chemicals. The standards were USP products. The structures of cefradine, cefalexin and cefadroxil are shown in Figure 1 . The Korean Food and Drug Administration (KFDA) donated all of the bulk drugs to the Research Project on the Quality Control of Standard Drugs. Methanol and water, both HPLC grade, were obtained from Merck (Darmstadt, Germany). Glacial acetic acid, sodium acetate and potassium dihydrogen phosphate were purchased from Sigma-Aldrich Chemical, Korea Ltd. (Seoul, Korea). All reagents were analytical-grade.
Preparation of mobile phases and samples. For HPLC analysis of substances related to cefradine, mobile phases and standard samples were prepared according to the "cefalexin method" described in the EP. For the development of the cefradine impurity test, samples were treated according to the cefadroxil sample preparation method described in the EP. Mobile phases were degassed by ultrasonication. The concentrations of the six bulk drug samples were similar to that of the standard solution.
Each of the six bulk drug samples was injected three times to obtain % area and % RSD data. The cefradine impurity test was completed according to the "cefalexin method" described in the EP within 8 hr and 40 min, producing three chromatograms for each bulk drug. The interval between sample injections was approximately 4 hr and 20 min. The cefradine impurity test performed according to the "cefadroxil method" was completed within 10 hr and 20 min, producing three chromatograms for each bulk drug. The sample injection interval was approximately 5 hr and 10 min.
Equipment. The HPLC system was a Waters (Milford, MA, USA) Alliance 2695 separations module system consisting of a 2996 photo diode detector interfaced with a PC data system. Chromatographic data were manipulated using Empower software from Waters Korea Ltd. (Seoul, Korea). HPLC separations were performed with a C 18 250 mm × 4.6 mm (UG120 5 μm particle size) column from Shiseido Capcell pak (Tokyo, Japan). The column operating temperature was maintained at 30 °C. Other HPLC conditions are summarized in Table 3 . Column length and sample temperature given in the EP were modified slightly in the present study to obtain comparable data.
Results and Discussion
Chromatographic results for the determination of impurities in cefradine with "cefalexin method". The HPLC conditions were those described for the "cefalexin method" in the EP to improve analysis of the impurities in cefradine over the TLC method. The ratio of the major impurity, cefalexin, and any other impurities in cefradine was checked with the "cefalexin method." The method was quite successful in determining the content of all impurities in cefradine. The method facilitated simultaneous determination of cefradine content, which is not possible with TLC method. Table 3 . HPLC conditions for the analysis of cefradine using the "cefalexin" and "cefadroxil" methods HPLC results for retention time and % area for each of the six peaks corresponding to the six (Sa A~F) bulk drugs are summarized in Table 4 and representative chromatograms for each bulk drug are shown in Figure 2 . The results of HPLC analysis summarized in Table 4 clearly demonstrate the ratio of cefradine, cefalexin and three or four unknown impurities, although the chromatograph baselines were somewhat unstable.
Method
According to EP specifications, the content of cefradine, when used as an active ingredient, should be not less than 90.0%. In addition, the content of cefalexin as a major impurity should be not more than 5.0%, while the content of any other extraneous impurities should not exceed 1.0%. Therefore, it was concluded that the cefradine bulk drugs, A, B, D, E and F, did not meet EP specifications, because the content of three or four unknown impurities was greater than 1.0%, as shown in Table 4 .
Chromatographic results for determination of impurities in cefradine with "cefadroxil method".
Determination of impurities in cefradine: As shown in Figure 1 , the structure of cefradine is similar to that of cefadroxil. Consequently, the chromatographic conditions described for the "cefadroxil method" except for the UV detection wavelength can be applied to the determination of impurities in cefradine. The UV detection wavelength for cefradine was set to 254 nm, as shown in Table 3 while the wavelength used for cefadroxil was 220 nm, according to the "cefadroxil method".
Representative chromatograms for the six cefradine (Sa A~F) bulk drugs are shown in Figure 3 . The baselines of the chromatograms shown in Figure 3 were much more stable than those obtained with the "cefalexin method" shown in Figure 2 . Retention time and % area for each of the six cefradine (Sa A~F) bulk drugs are summarized in Table 5 . The retention times of cefalexin and cefradine were approximately 16 and 18 min, respectively, with good reproducibility. The cefalexin content in each of the six cefradine bulk drugs tested was less than 5.0% and was within EP specifications. According to EP specifications, the content of any extraneous impurity in cefradine must be less than 1.0% (Table  2) . However, the impurity content observed at 21 min was greater than 1.0% for cefradine bulk drugs B, D, E and F. In addition, the total extraneous impurity content was more than 1.0% for all six cefradine bulk drugs. In this instance, none of the six cefradine bulk drugs tested, A, B, C, D, E and F, were deemed appropriate for use as drugs.
Comparison of the "cefalexin" and "cefadroxil" methods for the assay of cefradine bulk drugs. The precision of the two HPLC methods for determination of cefradine, cefalexin and any other detectable impurities in cefradine bulk drugs was compared. The % area and % RSD observed with the two methods for cefradine content in six cefradine bulk drugs are summarized in Table 6 . The % RSDs for the % areas observed with the "cefadroxil method" (0.02-0.08) were superior to those obtained with the "cefalexin method" (0.05-0.20). The % area and % RSD for the cefalexin content in six cefradine bulk drugs are also summarized in Table 7 . As shown in Table 7 , the % RSDs for the % areas obtained using the "cefadroxil method" (0.02-0.05) were also superior to those obtained with the "cefalexin method" (0.0-20.12). From the extended chromatograms shown in Figures 2 and 3 , it is evident that the stability of the chromatograph baseline was greater with the "cefadroxil method" than with the "cefalexin method." Overall, the "cefadroxil method" is concluded to be quite reliable in determining cefalexin, the major impurity in cefradine, and any other extraneous impurities in cefradine bulk drugs. 
Conclusions
In this study, two different HPLC methods were evaluated in their performance for determination of impurities in cefradine bulk drugs. Even though TLC method is prescribed as the official method for determination of extraneous impurities in cefradine by the EP, HPLC method is superior to TLC method in terms of simple sample preparation, greater sensitivity and reproducibility. Between the two HPLC methods, the "cefadroxil method" was found to be superior to the "cefalexin method" due to greater baseline stability and precision. The "cefadroxil method" would be a suitable replacement for TLC method as the official method for determination of impurities in cefradine. In our future study, the "cefadroxil method" will be extended to the quantitative analysis of cefaclor and amoxicillin, which are similar to cefadroxil in their structures.
